6-123393665-GC-G
Position:
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_006073.4(TRDN):c.1063del(p.Ala355LeufsTer9) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000138 in 1,454,254 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000014 ( 0 hom. )
Consequence
TRDN
NM_006073.4 frameshift
NM_006073.4 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.498
Genes affected
TRDN (HGNC:12261): (triadin) This gene encodes an integral membrane protein found in skeletal and cardiac muscle. The encoded protein plays a role in skeletal muscle excitation-contraction coupling as part of the calcium release complex and is required for normal skeletal muscle strength. This protein indirectly links triads and microtubules in skeletal muscle. Mutations in this gene are associated with cardiac arrythmia syndrome and some variants in this gene may be associated with sudden cardiac death. [provided by RefSeq, May 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 12 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 6-123393665-GC-G is Pathogenic according to our data. Variant chr6-123393665-GC-G is described in ClinVar as [Likely_pathogenic]. Clinvar id is 3075857.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TRDN | NM_006073.4 | c.1063del | p.Ala355LeufsTer9 | frameshift_variant | 13/41 | ENST00000334268.9 | NP_006064.2 | |
TRDN | NM_001251987.2 | c.1066del | p.Ala356LeufsTer9 | frameshift_variant | 13/21 | NP_001238916.1 | ||
TRDN | NM_001407315.1 | c.1006del | p.Ala336LeufsTer9 | frameshift_variant | 12/20 | NP_001394244.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TRDN | ENST00000334268.9 | c.1063del | p.Ala355LeufsTer9 | frameshift_variant | 13/41 | 1 | NM_006073.4 | ENSP00000333984 | A2 | |
TRDN-AS1 | ENST00000587106.6 | n.55+4191del | intron_variant, non_coding_transcript_variant | 5 | ||||||
TRDN | ENST00000662930.1 | c.1066del | p.Ala356LeufsTer9 | frameshift_variant | 13/21 | ENSP00000499585 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome AF: 0.00000138 AC: 2AN: 1454254Hom.: 0 Cov.: 30 AF XY: 0.00000138 AC XY: 1AN XY: 722848
GnomAD4 exome
AF:
AC:
2
AN:
1454254
Hom.:
Cov.:
30
AF XY:
AC XY:
1
AN XY:
722848
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Likely pathogenic
Submissions summary: Pathogenic:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Catecholaminergic polymorphic ventricular tachycardia Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Jun 30, 2022 | The p.Ala355fs variant in TRDN has not been previously reported in individuals with catecholaminergic polymorphic ventricular tachycardia (CPVT) and was absent from large population studies. This variant is predicted to cause a frameshift, which alters the protein’s amino acid sequence beginning at position 355 and leads to a premature termination codon 9 amino acids downstream. Loss of function of the TRDN gene is an established disease mechanism in autosomal recessive CPVT. In summary, although additional studies are required to fully establish its clinical significance, this variant meets criteria to be classified as likely pathogenic for autosomal recessive catecholaminergic polymorphic ventricular tachycardia. ACMG/AMP Criteria applied: PVS1, PM2_P. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at